Literature DB >> 32773943

Pemetrexed and cisplatin-induced linear hyperpigmentation of skin.

Deepak Vashisht1, Nikita Sharma2, Aradhana Sood3, Sukriti Baveja4.   

Abstract

Entities:  

Keywords:  Cisplatin; Hyperpigmentation; Linear; Pemetrexed; Skin

Year:  2019        PMID: 32773943      PMCID: PMC7399548          DOI: 10.1016/j.mjafi.2018.11.003

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


× No keyword cloud information.
  12 in total

1.  Pemetrexed-induced edema of the eyelid.

Authors:  Guillermo Guhl; Blanca Diaz-Ley; Javier Sanchez-Perez; Ulpino Jimenez; Amaro Garcia-Diez
Journal:  Lung Cancer       Date:  2010-05-21       Impact factor: 5.705

2.  Pemetrexed-associated urticarial vasculitis.

Authors:  Gilberto Lopes; Vladimir Vincek; Luis E Raez
Journal:  Lung Cancer       Date:  2005-12-19       Impact factor: 5.705

3.  Pemetrexed-induced hyperpigmentation of the skin.

Authors:  D Schallier; L Decoster; J de Greve
Journal:  Anticancer Res       Date:  2011-05       Impact factor: 2.480

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Pemetrexed in malignant pleural mesothelioma.

Authors:  Maitreyee Hazarika; Robert M White; Brian P Booth; Yong-Cheng Wang; Doo Y Lee Ham; Cheng Yi Liang; Atiqur Rahman; Jogarao V S Gobburu; Ning Li; Rajeshwari Sridhara; David E Morse; Richard Lostritto; Patricia Garvey; John R Johnson; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

6.  Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma.

Authors:  Katharina Buchinger; Rolf Stahel; Verena Niggemeier; Christoph Gubler; Daniel Franzen
Journal:  Lung Cancer       Date:  2013-03-19       Impact factor: 5.705

Review 7.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

8.  [Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer].

Authors:  C Tummino; F Barlesi; C Tchouhadjian; A M Tasei; C Gaudy-Marqueste; M A Richard; P Astoul
Journal:  Rev Mal Respir       Date:  2007-05       Impact factor: 0.622

9.  Localized cisplatin hyperpigmentation induced by pressure. A case report.

Authors:  Z Al-Lamki; P Pearson; N Jaffe
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

10.  Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.

Authors:  Serena Ricciardi; Silverio Tomao; Filippo de Marinis
Journal:  Ther Clin Risk Manag       Date:  2009-10-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.